The pharmaceutical industry constantly seeks high-quality intermediates to ensure the efficacy and safety of final drug products. For manufacturers focused on cardiovascular and peripheral vascular treatments, securing a dependable supply of key building blocks like 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one (CAS: 54197-66-9) is paramount. This quinolone derivative is a critical intermediate in the synthesis of Cilostazol, a widely used medication. Understanding the importance of sourcing this compound reliably is the first step for any procurement manager or R&D scientist.

When sourcing pharmaceutical intermediates, purity, consistency, and reliable supply are non-negotiable. 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one, typically appearing as a light yellow crystal, boasts a minimum purity of 97%. This high level of purity is essential to prevent side reactions and ensure the desired chemical transformations occur smoothly during the multi-step synthesis of Cilostazol. As a key supplier from China, we focus on maintaining these stringent quality standards. We understand that the price and availability of such intermediates directly impact production timelines and costs for our clients.

For businesses looking to purchase 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one, partnering with an experienced manufacturer offers significant advantages. It ensures not only consistent product quality but also a stable supply chain, mitigating risks associated with fluctuating market demands. Many pharmaceutical companies are actively seeking manufacturers who can provide bulk quantities, competitive pricing, and comprehensive technical documentation. Enquiries about a quote for this essential pharmaceutical intermediate are always welcome, as we aim to support your manufacturing needs effectively.

The role of 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one extends beyond just being a precursor to Cilostazol. Its unique quinoline structure makes it a valuable compound for broader research in organic synthesis and drug discovery. Researchers exploring novel therapeutic agents often find such intermediates indispensable for creating new molecular entities. Therefore, when you buy this compound, you are investing in a versatile chemical that fuels innovation across the pharmaceutical sector.

In conclusion, for any company requiring 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one, particularly for the synthesis of Cilostazol, it is crucial to select a supplier that prioritizes quality, reliability, and competitive pricing. We, as a dedicated manufacturer and supplier, are positioned to meet these demands, offering a robust solution for your critical intermediate needs. Contact us today to learn more about our product specifications and to request a quotation for your next project.